SavedAdd your journal

Journals / Klinik Psikofarmakoloji Bülteni / 2014 / Cilt: 24 - Sayı: 4

Oros-metilfenidat ır-metilfenidattan daha etkilidir: Dikkat eksikliği hiperaktivite bozukluğu olan Türk çocuklarında retrospektif bir araştırma

Osmotic release oral system Methylphenidate is more effective than Immediate release methylphenidate: A retrospective chart review in Turkish children with attention deficit hyperactivity disorder

Elif ERCAN
Deniz YÜCE
Ülkü ARDIC AKYOL
Eyüp Sabri ERCAN
Bürge KABUKÇU BAŞAY
Pages
342–349
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The total Turgay DSM-IV Based Child and Adolescent Behavior Disorders Screening and Rating Scale scores from both the parent and teacher forms decreased significantly in both groups over 8 weeks (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to evaluate the efficacy and safety of osmotic release oral system methylphenidate (OROS-MPH) compared with immediate release methylphenidate (IR-MPH) in Turkish children with attention deficit hyperactivity disorder (ADHD).
📊
Key Findings & Data:Method: The medical records of primary school-aged children, who were first-time referrals to the outpatient clinic, were reviewed; 67 children receiving OROS-MPH and 47 children receiving IR-MPH were recruited for the study.
💡
Conclusion & Impact:Results: The total Turgay DSM-IV Based Child and Adolescent Behavior Disorders Screening and Rating Scale scores from both the parent and teacher forms decreased significantly in both groups over 8 weeks (p
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to evaluate the efficacy and safety of osmotic release oral system methylphenidate (OROS-MPH) compared with immediate release methylphenidate (IR-MPH) in Turkish children with attention deficit hyperactivity disorder (ADHD). Method: The medical records of primary school-aged children, who were first-time referrals to the outpatient clinic, were reviewed; 67 children receiving OROS-MPH and 47 children receiving IR-MPH were recruited for the study. A total of 114 children receiving treatment for ADHD were evaluated over 8 weeks. Results: The total Turgay DSM-IV Based Child and Adolescent Behavior Disorders Screening and Rating Scale scores from both the parent and teacher forms decreased significantly in both groups over 8 weeks (p

Özet

Amaç: Bu çalışmanın amacı DEHB olan Türk çocukların- da IR-MPH ile karşılaştırıldığında OROS-MPHnın etkinlik ve güvenliğinin değerlendirilmesidir. Yöntem: Ayaktan hasta kliniğine ilk kez başvuran ilko- kul çağındaki çocukların tıbbi kayıtları gözden geçiril- miş, OROS-MPH alan 67 çocuk ile IR-MPH alan 47 çocuk çalışmaya alınmış, DEHB için tedavi gören toplam 114 çocuk 8 hafta boyunca takip edilmiştir. Bulgular: Hem aile hem de öğretmen değerlendirmele- rinde Turgay DSM-IVe Dayalı Çocuk ve Ergen Davranım Bozuklukları Tarama ve Değerlendirme Ölçeği puan- larında 8 hafta sonunda azalma izlenmiştir (p

🔖

Cite This Article

ERCAN, E., YÜCE, D., AKYOL, Ü. A., ERCAN, E. S., BAŞAY, B. K. (2022). Oros-metilfenidat ır-metilfenidattan daha etkilidir: Dikkat eksikliği hiperaktivite bozukluğu olan Türk çocuklarında retrospektif bir araştırma. Klinik Psikofarmakoloji Bülteni, Cilt: 24 - Sayı: 4, 342–349. https://ajindex.com/articles/574004

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiat 2007
  2. 164(6):942- 8. [CrossRef] 2. Nigg JT. Attention-deficit/hyperactivity disorder and adverse health outcomes. Clin Psychol Rev 2013
  3. 33(2):215- 28. [CrossRef] 3. Anastopoulos AD, Smith TF, Garrett ME, Morrissey- Kane E, Schatz NK, Sommer JL, et al. Self-Regulation of Emotion, Functional Impairment, and Comorbidity Among ChildrenWith AD/HD. J Atten Disord 2011
  4. 15(7):583-92. [CrossRef] 4. Barkley RA, Fischer M. The unique contribution of emotional impulsiveness to impairment in major life activities in hyperactive children as adults. J Am Acad Child Adolesc Psychiatry 2010
  5. 49(5):503-13. 5. Macneil LK, Xavier P, Garvey MA, Gilbert DL, Ranta ME, Denckla MB, et al. Quantifying excessive mirror overflow in children with attention-deficit/hyperactivity disorder Neurology 2011
  6. 76(7):622-8. [CrossRef] 6. Cole WR, Mostofsky SH, Larson JC, Denckla MB, Mahone EM. Age-related changes in motor subtle signs among girls and boys with ADHD. Neurology 2008 4
  7. 71(19):1514-20. 7. Breslau N, Breslau J, Peterson E, Miller E, Lucia VC, Bohnert K, et al. Change in teachers’ ratings of attention problems and subsequent change in academic achievement: a prospective analysis. Psychol Med 2010
  8. 40(1):159-66. [CrossRef] 8. Kupper T, Haavik J, Drexler H, Ramos-Quiroga JA, Wermelskirchen D, Prutz C, et al. The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents. Int Arch Occup Environ Health 2012
  9. 85(8):837-47. [CrossRef] 9. Barkley RA. Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood. Postgrad Med 2008
  10. 120(3):48-59. [CrossRef] 10. Beauchaine TP, Hinshaw SP, Pang KL. Comorbidity of Attention-Deficit/Hyperactivity Disorder and Early- Onset Conduct Disorder: Biological, Environmental, and Developmental Mechanisms. Clin Psychol-Sci Pr 2010
  11. 17(4):327-36. [CrossRef] 11. Na KS, Lee SI, Hong SD, Kim JH, Shim SH, Choi J, et al. Effect of osmotic-release oral system methylphenidate on learning skills in adolescents with attention-deficit/hyperactivity disorder: an open-label study. Int Clin Psychopharmacol 2013
  12. 28(4):184-92. 12. Punja S, Zorzela L, Hartling L, Urichuk L, Vohra S. Long- acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacy. B